Supreme Court allows mail-order of abortion pill mifepristone pending appeal
The justices kept FDA mail-order rules in place while Louisiana’s challenge continues, preserving access to a drug used in nearly two-thirds of U.S. abortions.
- On Thursday, May 14, 2026, the Supreme Court preserved access to the abortion drug mifepristone, rejecting lower-court restrictions that would have halted mail-order prescriptions while the legal challenge continues.
- The New Orleans-based 5th U.S. Circuit Court of Appeals ordered the FDA to change rules for the medication on May 1, responding to Louisiana's lawsuit that blocked mail-order access to the drug.
- Danco Laboratories, which manufactures the brand-name version Mifeprex, warned the ruling would be "direct, immediate, and chaotic," preventing patients from picking up prescriptions even in-person at pharmacies.
- Louisiana Attorney General Liz Murrill argued that "hundreds of abortions are occurring every month" in the state despite bans, while Justices Clarence Thomas and Samuel Alito dissented from the emergency order.
- Access will likely remain uninterrupted until next year as the case proceeds, though the FDA is currently reviewing safety protocols that could eventually overturn mail-order availability.
406 Articles
406 Articles
SCOTUS Allows Biden’s Mail-Order Abortion Scheme to Continue For Now
The Supreme Court on Thursday allowed the Biden administration's mail-order abortion scheme to continue as litigation plays out in lower courts. The post Supreme Court Allows Biden’s Mail-Order Abortion Scheme to Continue During Litigation appeared first on Breitbart.
Supreme Court halts lower court order on abortion pill access as Alito and Thomas dissent
The Supreme Court on Thursday blocked a federal appeals court ruling that would have restricted mail-order access to the abortion drug mifepristone, keeping current distribution rules in place while litigation continues. Justices Samuel Alito and Clarence Thomas each filed separate dissents, and neither pulled punches. The order halted a May 1 decision by the New...
SCOTUS Allows Women to Continue Accessing Abortion Medication by Mail as Lower Courts Consider Louisiana Challenge
The United States Supreme Court has moved to continue allowing women access to mifepristone, a drug used in medication-induced abortions, by mail while a challenge to the FDA’s policies winds its way through the lower courts. This comes after the Supreme Court issued two temporary stays earlier this month while they reviewed briefs submitted by [...] The post SCOTUS Allows Women to Continue Accessing Abortion Medication by Mail as Lower Courts C…
Ohio abortion pill access preserved by United States Supreme Court order
CLEVELAND -- A ruling by the U.S. Supreme Court means that in Ohio patients seeking abortions can continue to access the medication via telehealth and obtain their prescriptions in the mail.
The decision temporarily reinstates a 2023 federal rule challenged by the Republican-governed state of Louisiana, which had eased access to the drug.
Coverage Details
Bias Distribution
- 49% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
